Pharmacogenomic screening can identify patients with gene variants that predispose them
to the development of severe toxicity from fluoropyrimidine (FP) chemotherapy. Deficiency of …

Public participation in medical research and biobanking is considered key to advances in
scientific discovery and translation to improved health care. Cultural concerns relating to …

DNA databases have significant commercial value. Direct-to-consumer genetic testing
companies have built databanks using samples and information voluntarily provided by …

A body mass index (BMI)> 22kg/m2 is a risk factor for type 2 diabetes (T2D) in Aboriginal
Australians. To identify loci associated with BMI and T2D we undertook a genome-wide …

In this article, I discuss how returns of Ancestral Remains of Indigenous Australian
communities from overseas museums and other scientific institutions since the early 1990s …

Objective Understanding the origins of Aboriginal Australians is crucial in reconstructing the
evolution and spread of Homo sapiens as evidence suggests they represent the …

Advances in our understanding of genetic and rare diseases are changing the face of
healthcare. Crucially, the global community must implement these advances equitably to …

While human genetic research promises to deliver a range of health benefits to the
population, genetic research that takes place in Indigenous communities has proven …

As part of a (bio) colonial project, the biological information of Indigenous Peoples has
historically been under scientific scrutiny, with very limited benefits for communities and …

This article aims to explore the ethical issues arising from attempts to diversify genomic data
and include individuals from underserved groups in studies exploring the relationship …